申请人:Parker Michael F.
公开号:US20080027056A1
公开(公告)日:2008-01-31
The invention encompasses compounds of Formula I, including pharmaceutically acceptable salts, their pharmaceutical compositions, and their use in treating CNS disorders.
该发明涵盖了I式化合物,包括药学上可接受的盐、它们的制药组合物以及它们在治疗中枢神经系统疾病方面的用途。